DiamiR Biosciences Corp. (DIMR)

Chart not available yet

Data will show when the stock starts trading.

Market Cap	n/a
Revenue (ttm)	1.32M
Net Income (ttm)	-633,740
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About DIMR

DiamiR Biosciences is a molecular diagnostics company initially focused on the development and commercialization of innovative blood-based tests for detection and monitoring of Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD), Parkinson’s disease (PD), and other neurodegenerative diseases (NDs). The proprietary technology we developed is based on quantitative analysis of “organ-enriched”, i.e. present at higher concentration in specific organs or tissues, microRNAs in plasma. We believe that the technology can also be applied to diseas...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2009
• Employees: 5
• Stock Exchange: NASDAQ
• Ticker Symbol: DIMR
• Website: https://www.diamirbio.com/

Financial Performance

Financial numbers in USD